Pirfenidone

In the US, Pirfenidone (pirfenidone systemic) is a member of the drug class miscellaneous uncategorized agents and is used to treat Idiopathic Pulmonary Fibrosis.

US matches:

• Pirfenidone

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L04AX05

CAS registry number (Chemical Abstracts Service)

0053179-13-8

Chemical Formula

C12-H11-N-O

Molecular Weight

185

Therapeutic Categories

Anti-inflammatory agent

Antifibrotic agent

Treatment of idiopathic pulmonary fibrosis

Chemical Names

5-Metyl-1-phenyl-1-H-pyridin-2-one (JAN)

5-Metyl-1-phenyl-2(1H)-pyridone (WHO, USAN)

Foreign Names

• Pirfenidonum (Latin)
• Pirfenidon (German)
• Pirfénidone (French)
• Pirfenidona (Spanish)

Generic Names

• Pirfenidone (OS: USAN, JAN, BAN)
• AMR-69 (IS)
• S-7701 (IS)
• Pirfenidone (PH: BP 2018, Ph. Eur. 9)

Brand Names

• Esbreit 267mg
  Roche, Luxembourg
• Esbreit 801mg
  Roche, Luxembourg
• Esbriet
  AndersonBrecon, Georgia; Catalent, Russian Federation; Genentech, United States; Hoffmann-La Roche, Canada; Intermune, Cyprus; Intermune, Poland; Roche, Argentina; Roche, Belgium; Roche, Brazil; Roche, Czech Republic; Roche, Germany; Roche, Denmark; Roche, Estonia; Roche, Spain; Roche, Finland; Roche, France; Roche, Croatia (Hrvatska); Roche, Ireland; Roche, Lithuania; Roche, Latvia; Roche, Norway; Roche, New Zealand; Roche, Oman; Roche, Sweden; Roche, Turkey; Roche Products, Australia; Roche Products, United Kingdom; Roche Registration, Netherlands; Roche Registration, Romania; Roche Registration Limited, Iceland; Roche Registration Ltd, Greece; Roche Registration, Slovenia
• Esbriet 267 mg
  Roche, Hungary
• Esbriet 267mg
  Haemato Pharm, Austria; Roche, Israel; Roche Registration, Austria; Roche Pharma Schweiz, Switzerland
• Esbriet 534mg
  Roche Pharma Schweiz, Switzerland
• Esbriet 801mg
  Roche Pharma Schweiz, Switzerland
• Esgrinil
  Raffo, Argentina
• Fibridoner
  Dosa, Argentina
• Misofagan
  Tuteur, Argentina
• Oxitinol
  LKM, Argentina
• Performa
  Bago, Argentina
• Pirespa
  Shionogi Seiyaku, Japan
• Pirfect
  Nobel, Turkey

Glossary

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer